In the US, Gemzar (gemcitabine systemic) is a member of the drug class antimetabolites and is used to treat Breast Cancer, Breast Cancer - Metastatic, Non-Small Cell Lung Cancer, Ovarian Cancer and Pancreatic Cancer.
US matches:
Ingredient matches for Gemzar
Gemcitabine
Gemcitabine is reported as an ingredient of Gemzar in the following countries:
- Bangladesh
- Luxembourg
- Peru
- Russian Federation
- Slovenia
- Tunisia
Gemcitabine hydrochloride (a derivative of Gemcitabine) is reported as an ingredient of Gemzar in the following countries:
- Australia
- Austria
- Bahrain
- Belgium
- Bosnia & Herzegowina
- Brazil
- Bulgaria
- Canada
- Chile
- Colombia
- Croatia (Hrvatska)
- Czech Republic
- Denmark
- Egypt
- Estonia
- Finland
- France
- Germany
- Greece
- Hong Kong
- Hungary
- Iceland
- Indonesia
- Iran
- Iraq
- Ireland
- Israel
- Italy
- Japan
- Jordan
- Kenya
- Kuwait
- Latvia
- Lebanon
- Lithuania
- Luxembourg
- Malaysia
- Malta
- Mexico
- Netherlands
- New Zealand
- Nigeria
- Norway
- Oman
- Philippines
- Poland
- Portugal
- Qatar
- Romania
- Russian Federation
- Saudi Arabia
- Serbia
- Singapore
- Slovakia
- Slovenia
- South Africa
- Spain
- Sri Lanka
- Sweden
- Switzerland
- Syria
- Taiwan
- Tanzania
- Thailand
- Turkey
- Uganda
- United Arab Emirates
- United Kingdom
- United States
- Yemen
International Drug Name Search